Cash · 2011–2025
Elite Pharmaceuticals cash
$21.6M+146.6% · FY2025
Elite Pharmaceuticals (ELTP) reported $21.6M in cash for fiscal 2025, +146.6% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $21.6M | +146.6% | Open → |
| FY20242024-12-31 | $8.7M | +50.3% | Open → |
| FY20232023-12-31 | $5.8M | −67.5% | Open → |
| FY20222022-12-31 | $17.9M | +145.7% | Open → |
| FY20212021-12-31 | $7.3M | +34.7% | Open → |
| FY20202020-12-31 | $5.4M | +189.4% | Open → |
| FY20192019-12-31 | $1.9M | −49.2% | Open → |
| FY20182018-12-31 | $3.7M | −49.2% | Open → |
| FY20172017-12-31 | $7.2M | −45.5% | Open → |
| FY20162016-12-31 | $13.3M | +63.9% | Open → |
| FY20152015-12-31 | $8.1M | −2.1% | Open → |
| FY20142014-12-31 | $8.3M | +665.5% | Open → |
| FY20132013-12-31 | $1.1M | +1,546.2% | Open → |
| FY20122012-12-31 | $65,655 | −88.5% | Open → |
| FY20112011-12-31 | $568,691 | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +29.7%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals cash |url=https://companiesranked.com/en/company/elite-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/cash-on-handBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001493152-26-007104 · February 17, 2026
{{cite web |title=Elite Pharmaceuticals cash — 10-Q (0001493152-26-007104) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226007104/form10-q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.